HA-scientific-session-header

WFH Humanitarian Aid Program holds session for doctors and treaters

In December 2020, the WFH Humanitarian Aid Program held a scientific session for doctors and treaters to develop the awareness and knowledge of hemophilia in Central and South America. The webinar is part of an ongoing series of events developed by the Program to connect with bleeding disorders treaters in recipient countries.

Also available in: Français Español

In December 2020, the WFH Humanitarian Aid Program held a scientific session for doctors and treaters to develop the awareness and knowledge of hemophilia in Central and South America. The webinar is part of an ongoing series of events developed by the Program to connect with bleeding disorders treaters in recipient countries. The objective of the series is to ensure that the WFH understands the needs of treaters; is able to give them the tools they need to best support existing patients and identify new ones; and is also able to identify new treaters who can help with hemophilia care.

“Scientific Session on Front-Line Doctors and Second-Line Treaters” was held to improve knowledge of hemophilia as related to clinical diagnosis through history and physical examination, treatment regimens for acute and chronic bleeds, and the recognition and management of complications. The agenda topics were hemophilia as a differential diagnosis in prolonged bleeding, clinical and laboratory diagnosis of hemophilia, and the treatment of hemophilia using replacement therapy. The event ended with an open Q&A period. Almost 80 participants from 17 countries took part in the webinar.

Participants were from two important sets of carers for people with hemophilia (PWH): front-line physicians working in the primary care setting, such as clinics, local health centres, and second-line treaters. This latter group is made up of treaters working in hospitals who may not necessarily be hemophilia specialists, such as registrars, residents, and fellows-in-training, pediatricians, internists, and emergency room physicians. Training second-line treaters so that they can recognize the signs of hemophilia is absolutely critical for the bleeding disorders community, because early recognition leads to diagnosis and proactive management which can have a huge impact on the quality of life of patients.

Presentations were given by Arlette Ruiz-Saez, MD (Venezuela); Miguel Escobar, MD (U.S.A); and Santiago Bonanad, MD (Spain). Cesar Garrido, WFH President; Glenn Pierce, MD, PhD, WFH Vice President, Medical; and Barry Flynn, WFH Vice President, Finance, were also in attendance.

The event was very favorably received by attendees, with an overall satisfaction rate of 90%. The feedback was that the event covered all relevant topics for physicians in the front-line, reinforced knowledge of hemophilia, and used clear and simple language. All in all, attendees felt that the knowledge they gained from the webinar would have an immediate impact on their ability to effectively care for patients with a bleeding disorder—now and for the future.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and our Contributors, CSL Behring and Takeda.  To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.